维普中文期刊产品整合服务
68篇 您的检索式:作者名="FARRELL AM"
    题名 作者 年代 出处 被引量
1Cytokine alterations in lichen sclerosus: an immunohistochemical study显示文摘FARRELL AM DEAN D MILLARD PR 2006Br J Dermatol2006,155,5:1
2Staphylococcal scalded-skin syndrome 显示文摘Farrell AM 1999Lancet1999,354,9152:1
3An innovative phase I clinical study demonstrates inhibition of FLT3 phosphorylation by SUl1248 in acute myeloid leukemia patients显示文摘O'Farrell AM Foran JM Fiedler W 2003Clin Cancer Res2003,9,15:1
4Propionibacterium acnes, a resident of lipid-rich human skin, produces a 33 kDa extracellular lipase encoded by gehA 显示文摘Miskin JE Farrell AM Cunliffe WJ 1997Microbiology1997,143,5:1
5IL-10 inhibits macrophage activation and proliferation by distinct signaling mechanisms: evidence for Stat3-dependent and-independent pathways显示文摘 Liu Y Moore KW 1998EMBO J1998,17,4:1
6Routine administration of anti-D: the ethical case for offering pregnant women fetal RhD genotyp- ing and a review of policy and practice显示文摘Kent J Farrell AM Soothill P 2014BMC Pregn Child- birth2014,25,14:1
7SUl1248 is a novel FLT3 tyrosine kinase inhibitor with potent activity in vitro and in vivo 显示文摘O'FARRELL AM ABRAMS TJ YUEN HA 2003Blood2003,101,9:1
8SU11248 is a novel FLT3 tyrosine kinase inhibitor with potent activity in vitro and in vivo显示文摘O’Farrell AM Abrams TJ Yuen HA 2003Blood2003,101,9:1
9Staphylococcal scalded-skin syndrome 显示文摘Farrell AM 1999Lancet1999,354,9182:1
10Maternal serum screening in Ontario using the triple marker test显示文摘Summers AM Farrell SA Huang T 2003J Med Screen2003,10,:1
11SU11248 is a novel FLT3 tyrosine kinase inhibitor with potent activity in vitro and in vivo 显示文摘O' Farrell AM Abrams TJ Yuen HA 2003Blood2003,101,25:1
12Staphylococcal scalded-skin syndrome显示文摘Farrell AM 1999Lancet1999,354,9182:1
13Staphylococal scalded -skin syadrome显示文摘Farrell AM 1999Lancet19991999,,:1
14Staphylococcal scalded skin syndrome显示文摘Farrell AM 1999Lancet1999,354,9182:1
15Childhood vulval pemphigoid: a clinical and immunopathological study of five Patients显示文摘Farrell AM Kirtschig G Dalziel KL 1999Br J Dermatol1999,140,2:1
16An innovative phase I clinical study demonstrates inhibition of FLT3 phosphorylation by SU11248 in acute myeloid leukemia patients显示文摘O'FARRELL AM FORAN JM FIEDLER W 2003Clin Cancer Res2003,9,15:1
17Transient ischemic attacks: predictability of future ischemic stroke or transient ischemic attack events显示文摘Gupta HV Farrell AM Mittal MK 2014Ther Clin Risk Manag2014,10,:1
18Heterogeneous macrolide resistance and gene conversion in the pneumococcus显示文摘Wolter N Smith AM Farrell DJ 2006Antimicrob Agents Chemother2006,50,1:1
19Triple - nega- tive breast cancer is not a contraindication for breast conservation 显示文摘Farrell CA Gonzalez - Angulo AM Xiudong L 2011Ann Surg Oneol2011,18,11:1
20Maternal serum screening in Ontario using the triple marker test显示文摘Summers AM Farrell SA Huang T 2003J Med Screen2003,10,3:1
返回顶部 每页显示:
共4页 首页 上一页 第1页 下一页 末页 /4 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费